The Administration has done important work to help lower drug prices. But the recent proposed rule on drug rebates – which would weaken the ability of Pharmacy Benefit Managers (PBMs) to negotiate lower prescription drug prices for patients – is a step in the wrong direction.


What the Rebate Rule Actually Does:

Instead of finding real solutions to lower out-of-control drug prices, this plan would be the newest Big Pharma bailout – giving billions more to big drug makers.

These are the facts:

The truth is – we need market-based solutions that focus on actually lowering drug prices by holding Big Pharma accountable and driving more competition. Learn more here.


What the Government is Saying:

The CBO budget projections concluded the impact of the Rule would include:

The CBO analysis bolsters findings from the Centers for Medicare and Medicaid Services (CMS) which determined that the Rebate Rule would result in:


What Seniors/Consumers are Saying:

A national survey that found an overwhelming 84 percent of Americans want policymakers to focus on policies that crack down on Big Pharma, rather than measures targeting rebates. The survey, commissioned by CSRxP and conducted by Morning Consult, also shows Americans put blame for rising prescription drug prices at the feet of Big Pharma, believe pharmacy benefit managers (PBMs) play a key role in the system and oppose the Administration’s proposed Rebate Rule:

Americans Want Policymakers to Focus on Holding Big Pharma Accountable

Americans Oppose the Administration’s Proposed Rebate Rule

A Morning Consult summary of the survey can be found HERE.


Not only does the Rebate Rule reward Big Pharma for its anti-competitive tactics, there is nothing in the rule that guarantees that drug manufacturers will lower prices by the full amount of existing rebates. Big Pharma’s track record proves that given the ability to raise prices, they will do just that.

We urge the administration to focus on those market-based solutions and abandon the Rebate Rule in light of the mounting evidence of its negative impact on seniors and taxpayers.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.